Skip to content
Companies
Partnerships
Initiatives
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Content
News
Original Content
About
About Flagship
People
Our Process
Our Values
Social Impact
Join Us
Our Culture
Open Roles
Flagship Fellowship
Open Search
Open Menu
News
2018
News
company
Moderna
All
Abiologics
Alltrna
Ampersand Biomedicines
Apriori Bio
Cellarity
CIBO Technologies
Cystic Fibrosis Foundation
Empress Therapeutics
Etiome
Flagship Pioneering
Foghorn Therapeutics
Generate:Biomedicines
Harbinger Health
Inari Agriculture
Indigo Agriculture
Invaio Sciences
KSQ Therapeutics
Lila Sciences
Metaphore Biotechnologies
Mirai Bio
Moderna
Montai Therapeutics
Novo Nordisk
ProFound™ Therapeutics
Prologue Medicines
Quotient Therapeutics
Repertoire® Immune Medicines
Ring Therapeutics
Sail Biomedicines
Sana Biotechnology
Seres Therapeutics
Terrana Biosciences
Tessera Therapeutics
Valo
Vesalius Therapeutics
YourBio Health
year
All
All
2025
2024
2023
domain
All
All
Human Health
Technologies
Sustainability
Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform
Moderna
01.09.2018
Dr. John Mendlein Joins Moderna as President, Corporate and Product Strategy
Moderna
01.03.2018
Prev
1
2
Next
Loading
Close Search
What are you looking for?
Search
Close Menu
Companies
Partnerships
Initiatives
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Content
News
Original Content
About
About Flagship
People
Our Process
Our Values
Social Impact
Join Us
Our Culture
Open Roles
Flagship Fellowship
Contact
Careers
News
Privacy Policy
Terms of Use